S&P 500 7,680.39 â–ŧ 31.37 (-0.41%) DOW 53,221.10 â–ŧ 338.89 (-0.63%) NASDAQ 26,306.73 â–ŧ 95.70 (-0.36%) US Markets Closed â€ĸ 08:09 PM ET

CUPR

Cuprina Holdings (Cayman) Limited

Price Chart

No historical data available

Latest Quote

$3.01

-0.12 (-3.83%)
Current Price
Previous Close $3.13
Open $3.05
Day High $3.06
Day Low $3.00
Volume 4,156
Fetched: 2026-08-30T10:49:24
Stock Information
Note: Financial values converted from SGD to USD
Shares Outstanding 921K
Total Debt $2.68M
Cash Equivalents $2.51M
Revenue $39K
Net Income $-3.67M
Sector Healthcare
Industry Medical Instruments & Supplies
Market Cap $8.07M
EPS (TTM) $-1.38
Exchange NCM
🌐 Visit Website
Recent Price History
No history data available. Data will be fetched automatically.
About Cuprina Holdings (Cayman) Limited

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste streams; and products using medical leeches for wound treatment. The company was founded in 2019 and is based in Singapore. Cuprina Holdings (Cayman) Limited operates as a subsidiary of Cuprina Holding Pte. Ltd.

📰 Latest News
No news articles available at the moment. Check back later for updates on CUPR.
Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $31,838 $32,110 $44,103 $27,269
Cost Of Revenue $39,729 $40,363 $50,443 $28,788
Total Revenue $39,222 $37,986 $79,218 $44,493
Operating Revenue $39,222 $37,986 $79,218 $44,493
Expenses
Interest Expense $11,575 $29,251 $44,483 $1,586
Total Expenses $3,629,852 $1,200,988 $888,705 $928,643
Rent Expense Supplemental $53,679 $39,803 $37,421 $25,189
Other Income Expense $-42,711 $6,328 $440 $31,102
Other Non Operating Income Expenses $54,886 $7,876 $2,408 $38,075
Net Non Operating Interest Income Expense $9,306 $-29,251 $-44,483 $-1,586
Interest Expense Non Operating $11,575 $29,251 $44,483 $1,586
Operating Expense $3,590,123 $1,160,625 $838,262 $899,855
Other Operating Expenses $-63,647 $-56,863 $6,731 $-11,377
Selling And Marketing Expense $6,207 $5,110 $5,299 $31,225
General And Administrative Expense $3,448,387 $997,732 $650,822 $621,524
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-3,673,834 $-1,226,749 $-880,091 $-860,408
Net Interest Income $9,306 $-29,251 $-44,483 $-1,586
Interest Income $20,881 - - -
Normalized Income $-3,576,237 $-1,225,201 $-878,123 $-853,435
Net Income From Continuing And Discontinued Operation $-3,673,834 $-1,226,749 $-880,091 $-860,408
Total Operating Income As Reported $-3,796,767 $-1,293,351 $-839,822 $-924,296
Net Income Common Stockholders $-3,673,834 $-1,226,749 $-880,091 $-860,408
Net Income $-3,673,834 $-1,226,749 $-880,091 $-860,408
Net Income Including Noncontrolling Interests $-3,673,834 $-1,226,749 $-880,091 $-860,408
Net Income Continuous Operations $-3,673,834 $-1,226,749 $-880,091 $-860,408
Earnings From Equity Interest Net Of Tax $-49,799 $-40,823 $-26,561 $-5,774
Pretax Income $-3,624,034 $-1,185,926 $-853,530 $-854,634
Interest Income Non Operating $20,881 - - -
Operating Income $-3,590,630 $-1,163,003 $-809,487 $-884,150
Depreciation Amortization Depletion Income Statement $20,820 $24,909 $21,220 $21,348
Depreciation And Amortization In Income Statement $20,820 $24,909 $21,220 $21,348
Gross Profit $-507 $-2,377 $28,775 $15,705
Special Income Charges - $0 $0 $-6,973
Per Share
Diluted EPS - $-0.45 $-0.32 $-0.33
Basic EPS - $-0.45 $-0.32 $-0.33
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-3,486,152 $-1,121,965 $-779,519 $-823,209
Total Unusual Items $-97,597 $-1,548 $-1,968 $-6,973
Total Unusual Items Excluding Goodwill $-97,597 $-1,548 $-1,968 $-6,973
Reconciled Depreciation $28,711 $33,162 $27,560 $22,866
EBITDA (Bullshit earnings) $-3,583,749 $-1,123,512 $-781,486 $-830,182
EBIT $-3,612,460 $-1,156,674 $-809,047 $-853,048
Diluted NI Availto Com Stockholders $-3,673,834 $-1,226,749 $-880,091 $-860,408
Tax Provision $0 $0 $0 $0
Gain On Sale Of Security $-97,597 $-1,548 $-1,968 -
Research And Development $178,355 $189,737 $131,857 $230,234
Selling General And Administration $3,454,594 $1,002,843 $656,121 $652,749
Other Gand A $2,607,686 $307,476 $89,548 $43,660
Insurance And Claims $38,619 $8,366 $7,072 $1,758
Rent And Landing Fees $41,679 $27,954 $25,572 $12,883
Salaries And Wages $760,403 $653,936 $528,630 $563,223
Diluted Average Shares - $2,137,231 $2,137,231 $2,063,533
Basic Average Shares - $2,137,231 $2,137,231 $2,063,533
Gain On Sale Of Ppe - $0 $0 $-6,973
Provision For Doubtful Accounts - $0 $22,333 $6,901
Fetched: 2026-08-19
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $3,974,110 $-3,505,823 $-2,277,578 $-1,397,935
Total Assets $6,685,531 $1,371,786 $1,246,532 $1,128,947
Total Non Current Assets $922,437 $69,968 $118,429 $131,257
Non Current Prepaid Assets $612,514 $0 - -
Current Assets $5,763,094 $1,301,818 $1,128,103 $997,690
Other Current Assets $2,882 - $13,757 $19,292
Current Deferred Assets $0 $1,000,088 $804,538 $104,838
Prepaid Assets $3,108,173 $114,891 $109,498 $78,711
Inventory $0 $1,360 $6,026 $5,110
Receivables $201,204 $93,919 $166,564 $345,920
Accounts Receivable $14,321 $20,745 $39,949 $32,798
Allowance For Doubtful Accounts Receivable $-38,635 $-38,635 $-38,635 $-16,302
Gross Accounts Receivable $52,956 $59,379 $78,584 $49,100
Cash Cash Equivalents And Short Term Investments $2,450,834 $91,560 $27,721 $443,818
Cash And Cash Equivalents $2,450,834 $91,560 $27,721 $443,818
Other Receivables - - - $1,956
Debt
Total Debt $379,469 $200,292 $95,764 $144,357
Long Term Debt And Capital Lease Obligation $262,370 $128,708 $45,211 $96,621
Long Term Debt $99,208 $128,708 $17,059 $33,939
Current Debt And Capital Lease Obligation $117,099 $71,585 $50,553 $47,736
Current Debt $30,444 $43,432 $16,390 $15,683
Other Current Borrowings $30,444 $43,432 $16,390 $15,683
Net Debt - $80,581 $5,728 -
Liabilities
Total Liabilities Net Minority Interest $2,711,421 $4,877,608 $3,524,110 $2,526,882
Total Non Current Liabilities Net Minority Interest $262,370 $128,708 $45,211 $96,621
Current Liabilities $2,449,052 $4,748,901 $3,478,899 $2,430,260
Payables And Accrued Expenses $2,331,952 $4,677,316 $3,428,346 $2,382,525
Payables $2,314,200 $4,677,252 $3,428,120 $2,382,461
Other Payable $6,323 $254,612 $294,909 $140,662
Accounts Payable $925 $0 $0 $0
Equity
Common Stock Equity $3,974,110 $-3,505,823 $-2,277,578 $-1,397,935
Total Equity Gross Minority Interest $3,974,110 $-3,505,823 $-2,277,578 $-1,397,935
Stockholders Equity $3,974,110 $-3,505,823 $-2,277,578 $-1,397,935
Gains Losses Not Affecting Retained Earnings $273,992 $-1,253 $243 $-205
Other Equity Adjustments $273,992 $-1,253 $243 $-205
Retained Earnings $-7,259,313 $-3,585,480 $-2,358,731 $-1,478,640
Long Term Equity Investment $0 $0 $0 $6,202
Other
Ordinary Shares Number $2,107,752 $2,137,231 $2,137,231 $2,137,231
Share Issued $2,107,752 $2,137,231 $2,137,231 $2,137,231
Tangible Book Value $3,974,110 $-3,505,823 $-2,277,578 $-1,397,935
Invested Capital $4,103,762 $-3,333,682 $-2,244,129 $-1,348,313
Working Capital $3,314,042 $-3,447,082 $-2,350,796 $-1,432,571
Capital Lease Obligations $249,817 $28,152 $62,315 $94,735
Total Capitalization $4,073,317 $-3,377,115 $-2,260,519 $-1,363,995
Additional Paid In Capital $10,936,945 $61,884 $61,884 $61,884
Capital Stock $22,487 $19,026 $19,026 $19,026
Common Stock $22,487 $19,026 $19,026 $19,026
Long Term Capital Lease Obligation $163,162 $0 $28,152 $62,682
Current Capital Lease Obligation $86,655 $28,152 $34,163 $32,053
Current Accrued Expenses $17,752 $64 $226 $64
Dueto Related Parties Current $2,306,952 $4,422,640 $3,133,211 $2,241,799
Investments And Advances $0 $0 $0 $6,202
Net PPE $309,923 $69,968 $118,429 $125,055
Accumulated Depreciation $-145,994 $-117,283 $-84,121 $-56,561
Gross PPE $455,917 $187,251 $202,550 $181,616
Other Properties $110,918 $75,543 $75,543 $57,172
Machinery Furniture Equipment $96,019 $87,385 $70,182 $35,116
Buildings And Improvements $248,980 $24,322 $56,825 $89,328
Properties $0 $0 $0 $0
Duefrom Related Parties Current $186,883 $73,175 $126,615 $311,167
Investmentsin Joint Venturesat Cost - - - $6,202
Fetched: 2026-08-19
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-7,226,043 $-988,818 $-756,989 $-1,466,660
Operating Activities
Operating Cash Flow $-7,180,269 $-971,614 $-703,552 $-1,454,043
Cash Flow From Continuing Operating Activities $-7,180,269 $-971,614 $-703,552 $-1,454,043
Operating Gains Losses $160,808 $39,455 $28,514 $13,468
Investing Activities
Capital Expenditure $-45,774 $-17,203 $-53,437 $-12,616
Investing Cash Flow $-45,774 $-17,203 $-53,437 $-24,593
Cash Flow From Continuing Investing Activities $-45,774 $-17,203 $-53,437 $-24,593
Financing Activities
Issuance Of Capital Stock $13,840,247 $0 $0 -
Financing Cash Flow $9,615,469 $1,054,153 $340,444 $1,319,484
Cash Flow From Continuing Financing Activities $9,615,469 $1,054,153 $340,444 $1,319,484
Net Other Financing Charges $-4,182,290 $915,461 $356,617 $1,334,779
Net Common Stock Issuance $13,840,247 $0 $0 -
Common Stock Issuance $13,840,247 $0 $0 -
Other
Repayment Of Debt $-42,488 $-18,530 $-16,173 $-15,295
Issuance Of Debt $0 $157,222 $0 $0
Interest Paid Supplemental Data $55,487 $174 $572 $1,586
End Cash Position $2,450,834 $91,560 $27,721 $443,818
Beginning Cash Position $91,560 $27,721 $443,818 $603,175
Effect Of Exchange Rate Changes $-30,151 $-1,496 $448 $-205
Changes In Cash $2,389,426 $65,335 $-416,545 $-159,152
Net Issuance Payments Of Debt $-42,488 $138,691 $-16,173 $-15,295
Net Long Term Debt Issuance $-42,488 $138,691 $-16,173 $-15,295
Long Term Debt Payments $-42,488 $-18,530 $-16,173 $-15,295
Long Term Debt Issuance $0 $157,222 $0 $0
Net PPE Purchase And Sale $-45,774 $-17,203 $-53,437 $-12,616
Purchase Of PPE $-45,774 $-17,203 $-53,437 $-12,616
Change In Working Capital $-3,696,087 $179,512 $98,050 $-634,565
Change In Other Current Assets $-3,503,840 $8,363 $-25,251 $-81,203
Change In Payables And Accrued Expense $-229,678 $97,133 $-36,053 $-209,951
Change In Accrued Expense $-228,753 $97,133 $-36,053 $-209,778
Change In Payable $-925 - - $-173
Change In Account Payable $-925 $0 $0 $-173
Change In Prepaid Assets $31,024 $54,811 $187,801 $-308,231
Change In Inventory $0 $0 $-915 $-5,110
Change In Receivables $6,408 $19,205 $-27,532 $-30,070
Changes In Account Receivables $6,408 $19,205 $-29,488 $-30,221
Other Non Cash Items $-2,993 $-1,660 $83 $-2,307
Provisionand Write Offof Assets $0 $0 $22,333 $6,902
Asset Impairment Charge $3,126 $4,666 $0 $0
Depreciation Amortization Depletion $28,711 $33,162 $27,560 $22,866
Depreciation And Amortization $28,711 $33,162 $27,560 $22,866
Depreciation $28,711 $33,162 $27,560 $22,866
Earnings Losses From Equity Investments $49,799 $40,823 $26,561 $5,774
Net Foreign Currency Exchange Gain Loss $111,009 $-1,369 $1,953 $825
Net Income From Continuing Operations $-3,673,834 $-1,226,749 $-880,091 $-860,408
Net Business Purchase And Sale - $0 $0 $-11,976
Purchase Of Business - $0 $0 $-11,976
Gain Loss On Sale Of PPE - $0 $0 $6,869
Income Tax Paid Supplemental Data - - $0 $0
Fetched: 2026-08-19